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CASE REPORTS
Patient 1
A two-year-old, spayed female Bull terrier (25.3 kg,
moderately obese) was referred to the Department of
Small Animal Medicine and Clinical Biology at the Fa-
culty of Veterinary Medicine (Ghent University) with
a five-day -history of lethargy, nausea, acute vomiting
and eating grass. She had been anorectic for 2 days.
Uptake of a foreign body and intoxication were possi-
ble causes according to the owner. Her maintenance
food consisted of Science Plan Adult Beef dry food
(Hill’s®, Breda, The Netherlands). The last 13 months
she had been receiving corticosteroids (Prednisolone®
0.4 mg/kg every other day) and cephalosporine (Cep-
hadroxil® 25mg/kg twice a day) for the treatment of an
allergic dermatitis. Physical examination revealed weak
femoral pulses and strong breathing sounds on aus-
cultation. The dog had a tense abdomen and showed a
prayer position. Rectal examination was unremarkable.
Initial blood examination (complete blood count
(CBC), serum biochemistry) showed anemia, hypona-
traemia, hypertryglyceridemia, azotemia and increased
alkaline phosphatase activity (Table 1). 
Abdominal radiographs were performed because
of abdominal pain and the possibility of a gastrointes-
tinal foreign body (Figures 1a and 1b). Focal loss of se-
rosal detail in the dorsal and right central abdomen sug-
gested free abdominal fluid and a localized peritonitis.
In the cardia of the stomach, 2 foreign bodies were pre-
sent. Radiographic signs suggestive of gastrointestinal
obstruction were not present. 
The dog was rehydrated with Hartmann’s solution
(90 ml/kg/24 hours). An intravenous treatment with ra-
nitidine, amoxicillin-clavulanic acid and methadone
was started (Table 2). No food or water was given
orally. Eight hours after onset of medical treatment the
dog underwent an exploratory celiotomy during which
a gastrotomy was performed to remove the foreign
bodies (2 pieces of rubber). Severe necrotizing pan-
creatitis was noticed and the pancreas showed adhe -
sions to the liver, right kidney and abdominal wall
(Figure 2). A moderate amount of free fluid was present
and sampled. This revealed a modified transudate that
contained non-degenerative neutrophils and red blood
cells. The results of aerobic and anaerobic bacterial cul-
tures of the abdominal fluid were negative. An abdo-
minal lavage was performed in an effort to remove the
enzymes and cytokines present (Caronna et al., 2009).
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ABSTRACT
Acute pancreatitis in 2 dogs is discussed. A possible underlying cause was present in 1 dog. The clinical
signs and routine blood results were unspecific and insufficient to confirm the diagnosis. Acute pancreatitis
was diagnosed during exploratory celiotomy (case 1) and by abdominal ultrasonography (case 2). Aggressive
medical treatment consisted of fluid administration, analgesics, anti-ulcer therapy, antibiotics, transfusion of
fresh frozen plasma (FFP) and nutritional support. Despite the presence of negative prognostic factors,
intensive therapy and monitoring resulted in complete recovery in both patients.
SAMENVATTING
In dit artikel worden 2 honden met acute pancreatitis besproken. Een mogelijke onderliggende oorzaak was
aanwezig in 1 geval. De klinische presentatie en de algemene bloedresultaten waren aspecifiek en onvoldoende om
de diagnose te bevestigen. De diagnose van acute pancreatitis werd bevestigd tijdens een exploratieve celiotomie in
geval 1 en met behulp van abdominale echografie in geval 2. De agressieve behandeling bestond uit vloeistoftherapie,
pijn- en antiulcermedicatie, antibiotica, plasmatransfusie en nutritionele ondersteuning. Ondanks de aanwezigheid
van negatieve prognostische factoren resulteerden een intensieve therapie en opvolging in een compleet herstel van
beide patiënten.
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Table 1. Results of CBC, biochemistry and coagulation profile of patient 1.
Blood results Patient 1 Reference range
Hematocrit (%) 32.9 43 - 59
White blood cells (103/mm3) 6.6 6 - 12
Thrombocytes (103/mm3) 189 150 - 500
Albumin (g/l) 22 20 - 30
Total protein (g/l) 60 60 - 80
Blood ureum nitrogen (mmol/l) 25.4 < 12
Creatinine (µmol/l) 358 < 72 + 1.2 x BW
Alkaline phosphatase (IU/l) 285 < 147
Alanine aminotransferase (IU/l) 41 < 120
Bile acids (µmol/l) 28 < 12
Glucose (mmol/l) 4.2 2.2 - 8.2
Sodium (mmol/l) 135.3 145 - 155
Potassium (mmol/l) 4.79 2.7 - 5
Calcium (mmol/l) 2.27 2.21 - 2.79
Cholesterol  (mmol/l) 8.38 2.40 - 9.67
Triglycerides (mmol/l) 10.9 0.07 - 1.53
Prothrombine time (sec) 10.5 5 - 11
APTT (sec) 72.1 10 – 20
D-Dimers (ng/ml) 889 < 250 (reference for humans)
Fibrinogen (mg/dl) 770 100 – 460
APTT = activated partial thromboplastin time
Table 2. Medications used during and after hospitalization in patients 1 and 2.
Active component Product used Dose
Amoxicillin-clavulanic acid Augmentin® 20 mg/kg IV q 8h
Clavubactin® 12.5 mg/kg PO q 12h
Enrofloxacine* Baytril® 5 mg/kg IV q 24h or 2.5 mg/kg PO q 12h
Heparin Heparin LEO® 75-150 IU/kg IV or SC q 6h
Methadone Mephenon® 0.1-0.2 mg/kg IV q 4h
Metoclopramide Primperan® 0.3 mg/kg IV or PO q 8h
Phenobarbital+ Natrium Phenobarbital® 5 mg/kg IM q 12h
Gardenal® 50 mg PO q 12h
Ranitidine Zantac® 2 mg/kg IV or PO q 12h
*: only used in patient 1; +: only used in patient 2
Figure 1b. Lateral radiographic image of the abdomen of patient 1. The
arrow points towards the 2 corpora aliena present in the cardia of the
stomach.
Figure 1a. Ventrodorsal radiographic image
of the abdomen of patient 1: loss of serosal
detail in the right cranial region (small
arrow). Two corpora aliena are present in
the cardia of the stomach (big arrow).
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To ensure appropriate post-operative nutritional sup-
port without stimulating pancreatic secretion, a trans-
cutaneous jejunal feeding tube (V-PFT-5-35, Cook
Medical Australia, Queensland) was inserted. Further,
to monitor urine production and ensure hygiene, a
10Fr indwelling urinary Foley catheter (Kendall Curity,
Tyco Healthcare UK, Hampshire) was placed.
Post-operatively, the dog was installed in the in-
tensive care unit and received maintenance (Sterofun-
din®43.2 ml/kg/24hours) and replacement (NaCl 0.9%
43.2 ml/kg/24hours) fluids. Treatment with intrave-
nous amoxicillin-clavulanic acid and ranitidine was
continued for 5 and 7 days, respectively. Intravenous
metoclopramide was initiated post-operatively, and in-
travenous methadone was continued for 5 days and
then weaned off over the next 2 days (Table 2). The vi-
tal parameters, as well as urine production, blood pres-
sure and blood glucose levels, were monitored during
hospitalization. To provide α-macroglobulines and be-
cause of the possibility of developing DIC, a fresh
frozen plasma transfusion (FFP) (60 ml/kg/24hours)
was started immediately after surgery. Unfractionated
heparin was added to the plasma to activate anti-
thrombin, and this was followed by subcutaneous ad-
ministration of heparin over the next 3 days (Table 2).
The blood work was repeated 1 hour after surgery: the
anemia had worsened mildly, probably due to dilution
by the pre- and intra-operative fluid therapy, and mild
thrombocytopenia and hypoalbuminemia had develo-
ped, but the renal values were decreasing. Because
thrombocytopenia can indicate the development of
disseminated intravascular coagulation (DIC), a ci-
trate-coagulated blood sample was taken to evaluate the
coagulation parameters. The coagulation results 1 day
after surgery confirmed the presence of DIC, based on
thrombocytopenia, moderately increased d-dimers and
prolonged activated partial thromboplastin time (Table
1). Because the dog developed fever the first day post-
operatively, intravenous followed by oral administra-
tion of enrofloxacine was added to the antibiotic treat-
ment for the next 4 days (Table 2). One day after
surgery, enteral feeding was started by the jejunal fee-
ding tube with Convalescense Support Instant (Royal
Canin®, Aimargues, France) (1/3 of Resting Energy Re-
quirements or RER=3077 kJ Metabolized Energy) di-
vided over 7 meals a day. The caloric amount was
slowly increased over 3 days to the RER, observing
that no vomiting occurred. Two days after surgery,
small amounts of water and food (Digestive Low Fat
canned food, Royal Canin®, Aimargues, France) were
presented orally every three hours. The dog’s appetite
returned soon and the amount of food presented orally
was increased during the further hospitalization, while
the infusion rate was gradually decreased and discon-
tinued on day 5. Tube feeding was discontinued on the
third day post-operatively, and the jejunal tube was re-
moved 3 days later. After 8 days of hospitalization, the
dog was discharged on an oral therapy of amoxicillin-
clavulanic acid and ranitidine for 1 week (Table 2). Her
diet consisted of Digestive Low Fat dry food (Royal
Canin®, Aimargues, France), divided over 3 meals
each day. The dog was followed by the referring vete-
rinarian, who informed us by telephone 2 months after
discharge that the dog had made a perfect clinical re-
covery, and that the measurement of canine trypsin like
immunoreactivity (cTLI) 2 months after discharge was
within reference range. 
Patient 2
A 4.5-year-old, male intact Boston terrier (8.9 kg,
slightly obese) was referred to the Department of Small
Animal Medicine and Clinical Biology at the Faculty
of Veterinary Medicine (Ghent University) with a two-
day history of dullness, anorexia and acute vomiting.
The dog had a history of primary epilepsy for 2 years,
for which it was receiving phenobarbital (Gardenal® 7
mg/kg twice daily) in combination with potassium
bromide (Epikal®). The epilepsy was well controlled.
A mild nasal and pharyngeal stridor due to brachyce -
phalic airway syndrome was present. At physical exa-
mination, all vital parameters were normal. A tense and
painful abdomen was the only abnormality observed.
Rectal examination was unremarkable. Blood analysis
(CBC, serum biochemistry) showed a severe leukocy-
tosis with a left shift, thrombocytosis, mild hypopro-
teinemia, hypoalbuminemia, azotemia, hyperglycemia
and increased liver enzymes (alkaline phosphatase,
alanine aminotransferase, gamma-glutamyl-trans -
ferase). Phenobarbital levels were within normal limits,
in contrast to those of potassium bromide, which were
above the toxic serum levels. Urinalysis revealed iso -
sthenuria, pyuria and hemoglobinuria (Table 3). 
A diagnosis of severe acute pancreatitis was esta-
blished on abdominal ultrasound: the entire right lobe
of the pancreas was swollen, hypoechoic and surroun-
ded by hyperechoic fat and a small amount of anechoic
fluid (Figure 3). A blood sample taken for coagulation
profile revealed severely increased d-dimers and fibri-
nogen (Table 3). 
The dog was hospitalized and received a FFP trans-
fusion at a rate of 60 ml/kg/24hours supplemented
with unfractionated heparin, NaCl 0.9% (81.6
ml/kg/24hours), methadone, amoxicillin-clavulanic
acid, ranitidine, metoclopramide and phenobarbital
(Table 2). The dog was fasted for 24 hours and then re-
Figure 2. Right pancreatic limb demonstrating necrotic
areas covered by fibrin.
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ceived small amounts of Digestive Low Fat canned
food (Royal Canin®, Aimargues, France) divided over
7 small meals per day. The dog vomited twice after his
second meal, and was therefore kept sober for an ad-
ditional 12 hours before feeding was recommenced.
Food intake was then gradually increased. After 4 days
of hospitalization, the dog was discharged on this diet,
and he also received oral amoxicillin-clavulanic acid
for 10 days and phenobarbital (Table 2). The dosage of
potassium bromide was slowly decreased over a period
of 15 days and then completely discontinued. Raniti-
dine and metoclopramide were continued for 1 extra
week (Table 2). At home, the dog recovered well. A fol-
low-up visit at 5 months after discharge revealed no
problems. His diet consisted of Digestive Low Fat dry
food (Royal Canin®, Aimargues, France), which the
owner combined with pasta, rice and chicken, supple-
mented with omega 3 fatty acids (fish oil). The changes
to the anti-epileptic therapy treatment did not result in
the occurrence of any seizures in the following 2
months.
DISCUSSION
The signalment of the 2 patients described is gross -
ly compatible with the current literature on acute pan-
Figure 3. Ultrasonographic image in patient 2: hypo -
echoic enlarged pancreas (big arrow) lined by hyper -
echoic mesentery (small arrow).
Table 3. Results of CBC, biochemistry, coagulation profile and urinalysis of patient 2.
Patient 2 Reference range
Blood results
Hematocrit (%) 49.6 43 - 59
White blood cells (/µl) 43120 6000 - 16000
Band neutrophils (/µl) 3881 0 - 300
Thrombocytes (/µl) 645000 164000 - 510000
Albumin (g/l) 25.2 31 - 44
Total protein (g/l) 49 54 - 76
Blood ureum nitrogen (mmol/l) 11.32 1.66 - 8.65
Creatinine (µmol/l) 50.4 60 +BW
Alkaline phosphatase (U/l) 565 < 123
Alanine aminotransferase(U/l) 247 < 52
Aspartate aminotransferase (U/l) 70 < 44
Gamma-glutamyl transferase (U/l) 31 < 8
Total bilirubin (µmol/l) < 1.7 < 3.9
Direct bilirubin (µmol/l) < 1.7 < 10.2
Glucose (mmol/l) 6.22 3.05 - 4.99
Sodium (mmol/l) 149 136 - 154
Potassium (mmol/l) 4.3 4 - 5.5
Cholesterol  (mmol/l) 7.84 2.4 - 9.67
Triglycerides (mmol/l) 1.23 0.07 - 1.53 
Prothrombine time (sec) 6.7 5 - 11
APTT (sec) 20.2 10 - 20
D-Dimers (ng/ml) 2807 < 250 (reference in humans)
Fibrinogen (mg/dl) 968 100 - 460
Phenobarbital (mg/l) 26 20 - 30
Potassium bromide (mg/l) 2400.25 750 – 1550
toxic dose > 2000
Urinalysis
White blood cells (/µl) 50 < 25
Red blood cells (/µl) 4 < 25
Crystals negative
pH 7 4.5 - 7
Specific gravity 1.016 1.015 – 1.035
Hemoglobin positive
Aceton, urobilinogen, bilirubin, leucocyte esterase, nitrite negative
Protein/creatinine ratio 10.53 < 0.5
Glucose (mmol/l) 1.943 0.333 – 1.11
Culture negative
APTT = activated partial thromboplastin time; BW = body weight
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creatitis in companion animals, although the Bull ter-
rier was rather young (Cook et al., 1993; Hess et al.,
1999; Bunch, 2003; Watson, 2004; Mix and Jones,
2006). The majority of acute pancreatitis cases are
classified as idiopathic (Watson, 2004; Watson, 2007b),
but the history of both patients revealed possible risk
factors. At the present time, corticosteroids have only
been proven to be a possible risk factor if high doses
are given for the treatment of intervertebral disc disease
(Watson, 2004). Since this was not the case in the Bull
terrier, which had only received a low dose of predni-
solone, it is questionable whether this medication was
the underlying cause of the disease. However, because
corticosteroids inhibit the clearance of proteases bound
to α-macroglobulines (Watson, 2004), it was advised
to cease this treatment. Gaskill and Cribb (2000) de-
tected a 29 times greater risk for developing acute
pancreatitis in epileptic dogs treated with potassium
bromide/phenobarbital combination therapy instead of
phenobarbital monotherapy. It was not clear, however,
whether the increased risk was due to the potassium
bromide or to the combination therapy. Because the le-
vel of potassium bromide exceeded the toxic dose in
the Boston terrier, the medication was tapered and fi-
nally discontinued since the epilepsy was well con-
trolled.
As expected with acute pancreatitis, the initial
complaints and blood work were rather vague in both
dogs, and too unspecific to be diagnostic. The rapid
reso lution of the azotemia in both dogs after initiation
of fluid therapy confirmed that the azotemia was rather
pre- renal (dehydration) than renal in origin. The in -
crease in alkaline phosphatase activity in both dogs
could have been due to cholestasis or to enzyme
induction by corticosteroids or phenobarbital. The in -
crease in alanine aminotransferase in patient 2, an
enzyme associated with hepatocellular damage, can be
explained by hypoxia, ischemia, inflammation or
phenobarbital ad ministration. Because of the severe
pancreatitis, the co agulation profile was determined in
both dogs. Disseminated intravascular coagulation
(DIC) could only be confirmed in the Bull terrier. The
Boston terrier only had severely increased d-dimers,
an abnormality that can be a sign of hypercoaguability
and thus a risk for developing DIC (Bunch, 2003).
Because it was impossible to get a diagnosis solely
based on the history and blood results, medical
imaging was performed in both patients. In the Bull
terrier, abdominal radiographs revealed signs of a
localized peritonitis suggestive of acute pancreatitis
(Bunch; 2003; Ruaux, 2003; Watson, 2004), but many
other causes could also explain this image. The most
important differential diagnosis in this dog was the
presence of a focal septic peritonitis caused by
perforation of the gastrointestinal tract secondary to
the foreign bodies. Because the 2 gastrointestinal
foreign bodies were already an indication to perform a
surgical exploration, no further diagnostics (such as
ultrasound or abdominocentesis) were performed to
look for other possible causes. The final diagnosis of
necrotizing pancreatitis was made during macroscopic
examination. Most likely, the pancreatitis was the
major contributor to the clinical signs since the
gastrointestinal foreign bodies did not cause severe
mucosal irritation or mechanical obstruction. In the
second patient, a diagnosis of acute pancreatitis was
highly suspected on abdominal ultrasonography,
which is a reliable test, but very machine and operator
dependent (Simpson and Lamb, 1995; Ruaux, 2003;
Watson, 2004; Mix and Jones, 2006). 
In none of the patients were serum amylase and li-
pase measured, because of the disadvantages of these
tests. In dogs, neither lipase nor amylase is pancreas
specific, and their values depend on renal clearance, the
use of steroids and the severity of the disease (Simp-
son and Lamb, 1995; Bunch, 2003; Ruaux, 2003; Wat-
son, 2004). Although serum amylase and lipase were
historically the standard tests for diagnosing acute pan-
creatitis in companion animals, these tests are no lon-
ger recommended (Simpson and Lamb, 1995; Bunch,
2003; Ruaux, 2003; Watson, 2004; Mix and Jones,
2006). Nowadays immunoassays, such as canine pan-
creatic lipase immunoreactivity (cPLI) and cTLI, are
preferred over enzymatic assays, because of the higher
specificity and sensitivity (Ruaux, 2003; Watson,
2004). In our patients, neither cTLI nor cPLI was mea-
sured during the disease, as the diagnosis had already
been either made during surgery or suspected at abdo-
minal ultrasonography. In addition, it would have taken
several days to get the results of the 2 tests. 
Biopsy of the pancreas remains the golden standard
to diagnose pancreatic pathologies (Newman, 2006).
Instead of invasive exploratory surgery, minimally in-
vasive laparoscopic biopsy techniques are available
that have been proven successful in the diagnosis of
pancreatitis (Webb and Trott, 2008). Having histolo-
gical biopsies to confirm the diagnosis is especially im-
portant in low-grade disease where other diagnostic
tests are non-conclusive. This was not the case in our
patients, however. Although macroscopic assessment
during surgical exploration (first patient) and ultra-
sound examination (second patient) are considered to
be less reliable diagnostic techniques, they were easily
capable of making a distinct diagnosis in these 2 dogs.
The basic rules for treating acute pancreatitis in
dogs are fluid therapy and the prevention of oral intake
(Bunch, 2003). Because of the presence of necrotizing
pancreatitis in the Bull terrier, it was expected that
oral intake needed to be delayed for a substantial
amount of time (Watson, 2007a). Therefore a choice
was made to place a jejunal feeding tube allowing
early enteral nutrition (Qin 2007). Enteral nutrition is
the most natural route for administering nutrients and
it improves the integrity and function of the intestinal
mucosa (Qin et al., 2002; Qin et al., 2003; Wortinger,
2006). Moreover, a recent study by Mansfield (2008)
showed that clinical abnormalities indicating poor in-
testinal integrity (e.g. no enteral food intake > 3 days,
hematochezia, melena, regurgitation) are some of the
most important negative prognostic indicators in dogs
with acute pancreatitis. This demonstrates the impor-
tance of early enteral nutrition for these patients. Both
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dogs received Digestive Low Fat (Royal Canin®, Ai-
margues, France), which contains only 5% fat, while
the low fiber content ensures high digestibility and
nutrient absorption. The key values of this type of diet
are summarized in Table 4.
Both patients were given FFP combined with un-
fractionated heparin to activate antithrombin. Plasma
also delivers proteinase inhibitors that bind pancreatic
enzymes (Watson, 2004). Antibiotics were used in
both dogs, because one had a severe form of necroti-
zing pancreatitis and developed fever, while the other
had a severe leukocytosis with a left shift. The use of
both enrofloxacine and amoxicillin-clavulanic acid
can be justified: the first type penetrates well into pan-
creatic tissue and has a wide spectrum, while the other
type of antibiotic is effective against many Gram-ne-
gative and Gram-positive aerobe micro-organisms and
obligate anaerobes (Ramsey, 2008). Both dogs received
metoclopramide as anti-emetic therapy. The use of this
medication can be debated, because as a gastroproki-
neticum it can cause stimulation of the pancreas (De la
Puente-Redondo et al., 2007). Maropitant, a strong
anti-emeticum that inhibits both central and peripheral
causes of vomiting (De la Puente-Redondo et al.,
2007), seems more appropriate for these patients, but
was not yet available at the time. Both patients reco-
vered well, even though the prognosis in the Bull ter-
rier was initially guarded because of the severity of the
pancreatitis and the development of DIC.
CONCLUSION 
Although pancreatitis is usually idiopathic, sear-
ching for an underlying risk factor is mandatory to suc-
cessfully treat the episode and prevent recurrence. Ag-
gressive medical treatment with fluids, pancreatic rest,
early nutritional support, transfusion of FFP, antibiotic
therapy, anti-ulcer medication and analgesics is man-
datory. Although negative prognostic factors were pre-
sent, intensive care monitoring and therapy led to fa-
vorable outcome in both dogs. 
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